Kontrol Technologies Corp. has been selected by a large medical facility (the "Customer") in the USA for a Continuous emission Monitoring ("CEM") solution. The Customer operates across the USA and for industry competitive purposes the Customer will not be named.

Since January 2023 the Company has reduced its debt obligations by approximately $4 million. The Company remains in compliance with its secured lender, including interest and principal payments and operating with EBITDA profitability (earnings before interest taxes and depreciation). The Company is in the process of rebranding and further integrating multiple operating subsidiaries to better position the Kontrol brand, increase synergies and operating efficiencies with an emphasis on organic growth.